Geeta Krishnapriyan, MD
Internal Medicine · Campbell
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 12
- 1 carrier
- Offices
- 4
Offices
4 locations · University Healthcare Alliance · 334 clinicians in this group
Looking this up.
Hospitals listed: 057190 · El Camino Health · Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
12 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Krishnapriyan’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$70,492
Medicare paid this office $70,492 for 392 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 320 | $41,303 | $79 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 59 | $9,032 | $153 |
| Return visit (30+ min) | 35 | $3,726 | $106 |
| New patient visit (30+ min) | 26 | $2,267 | $87 |
| Influenza vaccine split virus, preservative free | 24 | $1,924 | $80 |
See all 10 services
| Short return visit (20+ min) | 320 | $41,303 | $79 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 59 | $9,032 | $153 |
| Return visit (30+ min) | 35 | $3,726 | $106 |
| New patient visit (30+ min) | 26 | $2,267 | $87 |
| Influenza vaccine split virus, preservative free | 24 | $1,924 | $80 |
| New patient visit (60+ min) | 11 | $1,900 | $173 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 88 | $1,426 | $15 |
| Telephone medical discussion with physician, 11-20 minutes | 14 | $1,068 | $67 |
| Administration of influenza virus vaccine | 26 | $994 | $38 |
| Automated urinalysis test | 12 | $26 | $2 |
Who their Medicare patients are
392 Original Medicare patients in 2024. Average age 75 · Under 65 5% · 85 and older 16% · Women 68% · Also on Medicaid 11% · Health risk score 1.02. At or below the middle of the specialty; the typical internal medicine clinician is at 1.76.
Conditions among them: High blood pressure 63% · Diabetes 23% · Coronary heart disease 18% · Depression 16% · Cancer 14% · Chronic kidney disease 13% · Atrial fibrillation 11% · Heart failure 9% · COPD 7% · Dementia 7% · Stroke 7%.
The office billed $259,448, Medicare allowed $93,113 and paid $70,492; for 901 services of 29 kinds; $4,044 of it was for drugs given in the office and $66,449 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 392 | 901 | 75 | 1.02 | $259,448 | $70,492 |
| 2023 | 302 | 1,474 | 77 | 1.08 | $256,700 | $67,991 |
| 2022 | 282 | 1,130 | 76 | 1.05 | $230,728 | $65,231 |
| 2021 | 168 | 514 | 77 | 0.92 | $135,905 | $34,217 |
| 2020 | 88 | 297 | 77 | 1.00 | $69,289 | $15,745 |
| 2019 | 121 | 551 | 76 | 0.87 | $119,683 | $25,685 |
| 2018 | 106 | 396 | 77 | 0.94 | $92,296 | $21,453 |
| 2017 | 114 | 440 | 77 | 1.00 | $100,176 | $27,042 |
| 2016 | 93 | 567 | 78 | 0.78 | $87,467 | $24,697 |
| 2015 | 123 | 316 | 78 | 0.95 | $65,841 | $17,078 |
| 2014 | 101 | 297 | 78 | 0.87 | $52,461 | $15,450 |
| 2013 | 95 | 345 | 77 | 0.85 | $33,737 | $15,182 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 12 services
| Short return visit (20+ min) | 196 | $26,512 | $79 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 36 | $5,612 | $156 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 15 | $4,195 | $280 |
| New patient visit (45+ min) | 29 | $3,798 | $131 |
| Telephone medical discussion with physician, 11-20 minutes | 37 | $3,330 | $79 |
| Return visit (30+ min) | 37 | $3,281 | $84 |
| Influenza vaccine split virus, preservative free | 36 | $2,566 | $71 |
| Telephone medical discussion with physician, 21-30 minutes | 21 | $2,540 | $102 |
| New patient visit (30+ min) | 24 | $2,333 | $97 |
| Administration of influenza virus vaccine | 41 | $1,515 | $37 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 15 | $874 | $51 |
| Administration of pneumococcal vaccine | 15 | $554 | $37 |
2022: 13 services
| Short return visit (20+ min) | 140 | $15,990 | $78 |
| Return visit (30+ min) | 73 | $9,795 | $103 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 22 | $6,109 | $278 |
| Telephone medical discussion with physician, 11-20 minutes | 44 | $5,054 | $74 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 21 | $3,327 | $158 |
| Influenza vaccine split virus, preservative free | 47 | $3,221 | $69 |
| Long return visit (40+ min) | 20 | $2,912 | $146 |
| New patient visit (45+ min) | 20 | $2,604 | $130 |
| Telephone medical discussion with physician, 21-30 minutes | 18 | $2,080 | $104 |
| Administration of influenza virus vaccine | 48 | $1,787 | $37 |
| New patient visit (30+ min) | 19 | $1,496 | $79 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 15 | $1,042 | $52 |
| Administration of pneumococcal vaccine | 23 | $859 | $37 |
2021: 6 services
| Short return visit (20+ min) | 76 | $10,376 | $74 |
| Return visit (30+ min) | 46 | $5,889 | $111 |
| Telephone medical discussion with physician, 11-20 minutes | 46 | $5,398 | $76 |
| Influenza vaccine split virus, preservative free | 17 | $1,105 | $65 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 14 | $859 | $48 |
| Administration of influenza virus vaccine | 17 | $372 | $22 |
2020: 5 services
| Short return visit (20+ min) | 47 | $3,957 | $51 |
| Return visit (30+ min) | 24 | $2,460 | $82 |
| Telephone medical discussion with physician, 11-20 minutes | 22 | $1,871 | $65 |
| Influenza vaccine split virus, preservative free | 21 | $1,238 | $59 |
| Administration of influenza virus vaccine | 21 | $436 | $21 |
2019: 7 services
| Short return visit (20+ min) | 73 | $8,106 | $56 |
| Return visit (30+ min) | 44 | $3,964 | $73 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 18 | $2,551 | $142 |
| Influenza vaccine split virus, preservative free | 31 | $1,741 | $54 |
| Administration of influenza virus vaccine | 32 | $677 | $21 |
| Administration of pneumococcal vaccine | 16 | $328 | $21 |
| Urinalysis, manual test | 11 | $41 | $3 |
2018: 5 services
| Return visit (30+ min) | 64 | $6,413 | $74 |
| Short return visit (20+ min) | 58 | $6,251 | $58 |
| Influenza vaccine split virus, preservative free | 31 | $1,657 | $52 |
| Administration of influenza virus vaccine | 31 | $823 | $26 |
| Administration of pneumococcal vaccine | 15 | $386 | $26 |
2017: 7 services
| Return visit (30+ min) | 66 | $8,942 | $81 |
| Short return visit (20+ min) | 74 | $5,777 | $55 |
| Pneumococcal vaccine, 13-valent | 19 | $3,485 | $183 |
| Influenza vaccine split virus, preservative free | 31 | $1,483 | $48 |
| Long return visit (40+ min) | 12 | $1,354 | $113 |
| Administration of influenza virus vaccine | 32 | $1,033 | $32 |
| Administration of pneumococcal vaccine | 24 | $775 | $32 |
2016: 6 services
| Return visit (30+ min) | 56 | $6,917 | $81 |
| Pneumococcal vaccine, 13-valent | 35 | $6,179 | $177 |
| Short return visit (20+ min) | 52 | $5,718 | $55 |
| Influenza vaccine split virus, preservative free | 31 | $1,260 | $41 |
| Administration of pneumococcal vaccine | 36 | $1,140 | $32 |
| Administration of influenza virus vaccine | 32 | $1,014 | $32 |
2015: 5 services
| Short return visit (20+ min) | 91 | $6,745 | $53 |
| Return visit (30+ min) | 51 | $5,743 | $78 |
| Influenza vaccine split virus, preservative free | 25 | $914 | $35 |
| Administration of influenza virus vaccine | 26 | $858 | $32 |
| Administration of pneumococcal vaccine | 11 | $349 | $32 |
2014: 5 services
| Short return visit (20+ min) | 72 | $6,965 | $57 |
| Return visit (30+ min) | 38 | $4,031 | $86 |
| Administration of influenza virus vaccine | 39 | $1,116 | $29 |
| Influenza vaccine split virus, preservative free | 34 | $1,112 | $33 |
| Automated urinalysis test | 11 | $39 | $3 |
2013: 5 services
| Short return visit (20+ min) | 62 | $6,222 | $46 |
| Return visit (30+ min) | 52 | $5,002 | $68 |
| Administration of influenza virus vaccine | 45 | $1,191 | $26 |
| Long return visit (40+ min) | 11 | $845 | $77 |
| Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone) | 45 | $531 | $12 |
Drugs they prescribed that Part D paid
$161,107
Pharmacies billed $161,107 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 1% of their Part D prescriptions (28 of 2,215) in 2024. Above the middle of the specialty; the typical internal medicine clinician is at 1%.
1,959 generic and fewer than 11 brand-name prescriptions · $161,107 in drug cost · 65 antibiotic prescriptions to 58 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 22 | $19,661 | $894 |
| Trulicity | 11 | $18,957 | $1,723 |
| Ozempic | 14 | $12,537 | $896 |
| Atorvastatin | 216 | $2,251 | $10 |
| Levothyroxine | 110 | $1,501 | $14 |
See all 51 drugs
| Eliquis | 22 | $19,661 | $894 |
| Trulicity | 11 | $18,957 | $1,723 |
| Ozempic | 14 | $12,537 | $896 |
| Atorvastatin | 216 | $2,251 | $10 |
| Levothyroxine | 110 | $1,501 | $14 |
| Synthroid | 15 | $1,266 | $84 |
| Lantus Solostar | 13 | $1,215 | $93 |
| Celecoxib | 13 | $1,160 | $89 |
| Losartan | 133 | $1,157 | $9 |
| Ventolin Hfa | 13 | $718 | $55 |
| Albuterol Sulfate Hfa | 29 | $710 | $24 |
| Amlodipine Besylate | 135 | $688 | $5 |
| Gabapentin | 36 | $678 | $19 |
| Donepezil | 30 | $646 | $22 |
| Oxycodone | 13 | $632 | $49 |
| Carvedilol | 38 | $621 | $16 |
| Ramipril | 34 | $548 | $16 |
| Valsartan | 21 | $542 | $26 |
| Tamsulosin | 28 | $531 | $19 |
| Mirtazapine | 14 | $490 | $35 |
| Metformin Hcl Er | 50 | $462 | $9 |
| Simvastatin | 39 | $455 | $12 |
| Omeprazole | 24 | $442 | $18 |
| Metoprolol | 42 | $441 | $11 |
| Rosuvastatin | 28 | $416 | $15 |
| Escitalopram | 25 | $383 | $15 |
| Lisinopril | 40 | $377 | $9 |
| Metformin | 48 | $355 | $7 |
| Propranolol | 19 | $352 | $19 |
| Bupropion Xl | 17 | $305 | $18 |
| Bupropion Hcl Sr | 18 | $241 | $13 |
| Fluticasone Propionate | 19 | $235 | $12 |
| Memantine | 12 | $233 | $19 |
| Pantoprazole | 18 | $221 | $12 |
| Losartan-Hydrochlorothiazide | 18 | $201 | $11 |
| Hydrochlorothiazide | 25 | $198 | $8 |
| Zolpidem | 27 | $195 | $7 |
| Nitrofurantoin Mono-Macro | 13 | $175 | $13 |
| Montelukast | 17 | $173 | $10 |
| Atenolol | 27 | $171 | $6 |
| Enalapril Maleate | 12 | $146 | $12 |
| Hydrocodone-Acetaminophen | 14 | $145 | $10 |
| Metoprolol | 17 | $133 | $8 |
| Trazodone | 20 | $132 | $7 |
| Azithromycin | 25 | $96 | $4 |
| Divalproex Sodium Er | 11 | $89 | $8 |
| Benazepril | 13 | $88 | $7 |
| Furosemide | 20 | $68 | $3 |
| Fluoxetine | 14 | $49 | $3 |
| Alendronate | 12 | $48 | $4 |
| Paxlovid | 15 | $0 | $0 |
Year by year
| 2024 | 2,215 | 339 | 1% (28) | None | $161,107 |
| 2023 | 2,191 | 330 | 1% (29) | 9% | $177,342 |
| 2022 | 1,813 | 259 | 2% (30) | 9% | $115,468 |
| 2021 | 1,136 | 145 | 4% (42) | 9% | $77,957 |
| 2020 | 1,045 | 121 | 2% (25) | 11% | $67,908 |
| 2019 | 1,342 | 157 | 3% (46) | None | $97,919 |
| 2018 | 1,227 | 141 | 4% (49) | 18% | $97,842 |
| 2017 | 1,149 | 133 | 5% (60) | 19% | $86,612 |
| 2016 | 923 | 103 | None | 17% | $62,422 |
| 2015 | 1,161 | 116 | None | 20% | $80,803 |
| 2014 | 1,280 | 71 | 0% (0) | 23% | $92,333 |
| 2013 | 1,289 | 75 | None | 23% | $93,018 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 56 drugs
| Eliquis | 26 | $21,233 | $817 |
| Atorvastatin | 204 | $2,564 | $13 |
| Losartan | 110 | $2,206 | $20 |
| Levothyroxine | 114 | $1,891 | $17 |
| Donepezil | 34 | $1,781 | $52 |
| Metoprolol | 81 | $1,705 | $21 |
| Amlodipine Besylate | 131 | $1,462 | $11 |
| Diclofenac | 26 | $1,192 | $46 |
| Ventolin Hfa | 11 | $1,168 | $106 |
| Valacyclovir | 17 | $895 | $53 |
| Escitalopram | 23 | $719 | $31 |
| Oxycodone | 15 | $655 | $44 |
| Gabapentin | 30 | $647 | $22 |
| Albuterol Sulfate Hfa | 20 | $608 | $30 |
| Lisinopril | 49 | $590 | $12 |
| Metformin | 49 | $582 | $12 |
| Nano 2nd Gen Pen Needle | 11 | $557 | $51 |
| Simvastatin | 47 | $539 | $11 |
| Ramipril | 26 | $502 | $19 |
| Atenolol | 28 | $459 | $16 |
| Ipratropium | 14 | $453 | $32 |
| Losartan-Hydrochlorothiazide | 22 | $425 | $19 |
| Rosuvastatin | 30 | $402 | $13 |
| Benazepril | 18 | $401 | $22 |
| Valsartan | 16 | $386 | $24 |
| Fluticasone Propionate | 26 | $381 | $15 |
| Carbidopa-Levodopa Er | 13 | $365 | $28 |
| Metformin Hcl Er | 40 | $343 | $9 |
| Alendronate | 25 | $342 | $14 |
| Montelukast | 16 | $328 | $20 |
| Tamsulosin | 20 | $288 | $14 |
| Triamterene-Hydrochlorothiazid | 12 | $286 | $24 |
| Hydralazine | 14 | $285 | $20 |
| Celecoxib | 18 | $252 | $14 |
| Sertraline | 15 | $251 | $17 |
| Furosemide | 39 | $235 | $6 |
| Memantine | 22 | $233 | $11 |
| Carvedilol | 38 | $221 | $6 |
| Finasteride | 12 | $201 | $17 |
| Pioglitazone | 14 | $199 | $14 |
| Paxlovid (Eua) | 17 | $166 | $10 |
| Pantoprazole | 17 | $150 | $9 |
| Zolpidem | 21 | $147 | $7 |
| Trazodone | 11 | $136 | $12 |
| Omeprazole | 12 | $133 | $11 |
| Hydrochlorothiazide | 26 | $131 | $5 |
| Propranolol | 13 | $127 | $10 |
| Bupropion Hcl Sr | 15 | $118 | $8 |
| Allopurinol | 13 | $115 | $9 |
| Amiodarone | 11 | $115 | $10 |
| Enalapril Maleate | 15 | $108 | $7 |
| Divalproex Sodium Er | 13 | $99 | $8 |
| Buspirone | 12 | $91 | $8 |
| Metoprolol | 13 | $73 | $6 |
| Azithromycin | 14 | $72 | $5 |
| Spironolactone | 12 | $39 | $3 |
2022: 40 drugs
| Vascepa | 12 | $8,018 | $668 |
| Toujeo Solostar | 12 | $5,184 | $432 |
| Atorvastatin | 184 | $2,104 | $11 |
| Levothyroxine | 100 | $1,598 | $16 |
| Donepezil | 22 | $1,543 | $70 |
| Losartan | 113 | $1,334 | $12 |
| Metoprolol | 62 | $1,108 | $18 |
| Diclofenac | 40 | $1,083 | $27 |
| Amlodipine Besylate | 144 | $840 | $6 |
| Losartan-Hydrochlorothiazide | 18 | $689 | $38 |
| Oxycodone | 13 | $689 | $53 |
| Rosuvastatin | 12 | $545 | $45 |
| Nano 2nd Gen Pen Needle | 11 | $539 | $49 |
| Gabapentin | 20 | $512 | $26 |
| Simvastatin | 62 | $399 | $6 |
| Ramipril | 26 | $387 | $15 |
| Hydrocodone-Acetaminophen | 13 | $370 | $28 |
| Pioglitazone | 17 | $311 | $18 |
| Lisinopril | 44 | $302 | $7 |
| Metformin | 56 | $291 | $5 |
| Alendronate | 23 | $280 | $12 |
| Atenolol | 29 | $263 | $9 |
| Carvedilol | 23 | $261 | $11 |
| Nitrofurantoin Mono-Macro | 11 | $249 | $23 |
| Hydralazine | 17 | $240 | $14 |
| Tamsulosin | 19 | $236 | $12 |
| Metformin Hcl Er | 30 | $227 | $8 |
| Triamterene-Hydrochlorothiazid | 14 | $216 | $15 |
| Pantoprazole | 16 | $151 | $9 |
| Furosemide | 27 | $135 | $5 |
| Fluticasone Propionate | 13 | $130 | $10 |
| Hydrochlorothiazide | 27 | $121 | $4 |
| Paxlovid (Eua) | 12 | $116 | $10 |
| Benazepril | 13 | $106 | $8 |
| Tizanidine | 14 | $104 | $7 |
| Bupropion Hcl Sr | 12 | $97 | $8 |
| Zolpidem | 14 | $88 | $6 |
| Lorazepam | 13 | $73 | $6 |
| Allopurinol | 12 | $57 | $5 |
| Citalopram Hbr | 12 | $46 | $4 |
2021: 25 drugs
| Levothyroxine | 61 | $1,226 | $20 |
| Atorvastatin | 110 | $1,224 | $11 |
| Losartan | 76 | $951 | $13 |
| Diclofenac | 32 | $923 | $29 |
| Oxycodone | 11 | $872 | $79 |
| Losartan-Hydrochlorothiazide | 18 | $707 | $39 |
| Metoprolol | 23 | $468 | $20 |
| Pravastatin | 13 | $408 | $31 |
| Amlodipine Besylate | 88 | $395 | $4 |
| Gabapentin | 18 | $367 | $20 |
| Metformin | 43 | $347 | $8 |
| Ramipril | 14 | $311 | $22 |
| Atenolol | 31 | $308 | $10 |
| Simvastatin | 43 | $278 | $6 |
| Alendronate | 31 | $255 | $8 |
| Lisinopril | 23 | $198 | $9 |
| Carvedilol | 11 | $192 | $17 |
| Omeprazole | 15 | $188 | $13 |
| Zolpidem | 21 | $187 | $9 |
| Pioglitazone | 11 | $173 | $16 |
| Famotidine | 15 | $134 | $9 |
| Hydrocodone-Acetaminophen | 22 | $132 | $6 |
| Mirtazapine | 12 | $97 | $8 |
| Escitalopram | 11 | $80 | $7 |
| Hydrochlorothiazide | 13 | $50 | $4 |
2020: 26 drugs
| Diclofenac | 40 | $1,218 | $30 |
| Losartan | 77 | $1,174 | $15 |
| Synthroid | 12 | $1,151 | $96 |
| Levothyroxine | 60 | $1,116 | $19 |
| Atorvastatin | 78 | $1,080 | $14 |
| Ultra-Fine Nano Pen Needle | 16 | $784 | $49 |
| Losartan-Hydrochlorothiazide | 17 | $715 | $42 |
| Pravastatin | 23 | $634 | $28 |
| Metformin | 59 | $456 | $8 |
| Gabapentin | 22 | $381 | $17 |
| Atenolol | 38 | $361 | $9 |
| Potassium Chloride | 13 | $295 | $23 |
| Amlodipine Besylate | 72 | $282 | $4 |
| Simvastatin | 26 | $266 | $10 |
| Metoprolol | 11 | $220 | $20 |
| Omeprazole | 11 | $211 | $19 |
| Alendronate | 31 | $173 | $6 |
| Tramadol | 12 | $172 | $14 |
| Carvedilol | 11 | $167 | $15 |
| Lisinopril | 23 | $151 | $7 |
| Hydrochlorothiazide | 22 | $104 | $5 |
| Clopidogrel | 13 | $80 | $6 |
| Benazepril | 15 | $65 | $4 |
| Metformin Hcl Er | 12 | $56 | $5 |
| Escitalopram | 11 | $50 | $5 |
| Hydrocodone-Acetaminophen | 12 | $35 | $3 |
2019: 35 drugs
| Janumet | 12 | $5,428 | $452 |
| Synthroid | 21 | $1,754 | $84 |
| Metoprolol | 37 | $1,333 | $36 |
| Tolterodine Tartrate Er | 16 | $1,189 | $74 |
| Atorvastatin | 76 | $1,161 | $15 |
| Losartan | 95 | $1,086 | $11 |
| Proair Hfa | 11 | $1,047 | $95 |
| Levothyroxine | 58 | $1,022 | $18 |
| Oxycodone | 12 | $1,019 | $85 |
| Pravastatin | 35 | $750 | $21 |
| Amlodipine Besylate | 98 | $668 | $7 |
| Voltaren | 12 | $655 | $55 |
| Diclofenac | 17 | $538 | $32 |
| Omeprazole | 25 | $525 | $21 |
| Ramipril | 26 | $494 | $19 |
| Metformin | 46 | $485 | $11 |
| Gabapentin | 17 | $471 | $28 |
| Atenolol | 43 | $399 | $9 |
| Losartan-Hydrochlorothiazide | 21 | $345 | $16 |
| Hydrocodone-Acetaminophen | 21 | $295 | $14 |
| Benazepril | 21 | $291 | $14 |
| Alendronate | 43 | $245 | $6 |
| Lisinopril | 25 | $245 | $10 |
| Montelukast | 11 | $239 | $22 |
| Simvastatin | 30 | $234 | $8 |
| Fluticasone Propionate | 16 | $227 | $14 |
| Carvedilol | 11 | $214 | $19 |
| Escitalopram | 14 | $136 | $10 |
| Metformin Hcl Er | 17 | $136 | $8 |
| Dutasteride | 12 | $130 | $11 |
| Sertraline | 11 | $104 | $9 |
| Tramadol | 12 | $97 | $8 |
| Hydrochlorothiazide | 17 | $68 | $4 |
| Azithromycin | 13 | $65 | $5 |
| Clopidogrel | 12 | $52 | $4 |
2018: 27 drugs
| Diltiazem 24hr Er (Cd) | 12 | $2,303 | $192 |
| Synthroid | 22 | $1,603 | $73 |
| Levothyroxine | 72 | $1,233 | $17 |
| Proair Hfa | 12 | $1,144 | $95 |
| Atorvastatin | 81 | $1,107 | $14 |
| Tolterodine Tartrate Er | 11 | $994 | $90 |
| Oxycodone | 12 | $984 | $82 |
| Metoprolol | 27 | $870 | $32 |
| Pravastatin | 39 | $829 | $21 |
| Losartan | 78 | $795 | $10 |
| Ultra-Fine Nano Pen Needle | 16 | $738 | $46 |
| Amlodipine Besylate | 101 | $674 | $7 |
| Ramipril | 18 | $418 | $23 |
| Metformin | 39 | $346 | $9 |
| Valsartan-Hydrochlorothiazide | 11 | $325 | $30 |
| Hydrocodone-Acetaminophen | 33 | $290 | $9 |
| Omeprazole | 18 | $269 | $15 |
| Losartan-Hydrochlorothiazide | 27 | $268 | $10 |
| Atenolol | 25 | $226 | $9 |
| Montelukast | 17 | $204 | $12 |
| Fluticasone Propionate | 18 | $189 | $11 |
| Simvastatin | 31 | $168 | $5 |
| Alendronate | 32 | $155 | $5 |
| Metformin Hcl Er | 17 | $130 | $8 |
| Lisinopril | 19 | $95 | $5 |
| Hydrochlorothiazide | 17 | $62 | $4 |
| Quetiapine | 11 | $37 | $3 |
2017: 28 drugs
| Nexium | 12 | $3,074 | $256 |
| Trilipix | 11 | $2,861 | $260 |
| Diltiazem 24hr Er | 11 | $2,480 | $225 |
| Tolterodine Tartrate Er | 12 | $1,307 | $109 |
| Pravastatin | 41 | $1,035 | $25 |
| Synthroid | 18 | $1,010 | $56 |
| Atorvastatin | 60 | $816 | $14 |
| Levothyroxine | 40 | $746 | $19 |
| Losartan | 68 | $671 | $10 |
| Amlodipine Besylate | 99 | $664 | $7 |
| Metoprolol | 18 | $634 | $35 |
| Ultra-Fine Nano Pen Needle | 14 | $602 | $43 |
| Ramipril | 16 | $495 | $31 |
| Hydrocodone-Acetaminophen | 43 | $476 | $11 |
| Metformin | 47 | $448 | $10 |
| Tamsulosin | 15 | $360 | $24 |
| Metformin Hcl Er | 26 | $324 | $12 |
| Alendronate | 36 | $228 | $6 |
| Simvastatin | 32 | $213 | $7 |
| Atenolol | 20 | $198 | $10 |
| Lovastatin | 16 | $195 | $12 |
| Omeprazole | 17 | $188 | $11 |
| Fluticasone Propionate | 13 | $168 | $13 |
| Azithromycin | 16 | $159 | $10 |
| Clopidogrel | 11 | $135 | $12 |
| Hydrochlorothiazide | 24 | $114 | $5 |
| Benazepril | 11 | $93 | $8 |
| Lisinopril | 14 | $74 | $5 |
2016: 27 drugs
| Nexium | 12 | $3,074 | $256 |
| Trilipix | 12 | $2,957 | $246 |
| Diltiazem 24hr Er | 12 | $2,670 | $222 |
| Tolterodine Tartrate Er | 11 | $1,385 | $126 |
| Pravastatin | 41 | $1,003 | $24 |
| Valsartan | 11 | $870 | $79 |
| Pioglitazone-Metformin | 11 | $728 | $66 |
| Atorvastatin | 41 | $670 | $16 |
| Levothyroxine | 30 | $596 | $20 |
| Metoprolol | 21 | $564 | $27 |
| Bd Ultra-Fine Pen Needle | 13 | $509 | $39 |
| Losartan | 57 | $493 | $9 |
| Clopidogrel | 27 | $435 | $16 |
| Amlodipine Besylate | 68 | $359 | $5 |
| Metformin | 41 | $293 | $7 |
| Alendronate | 32 | $267 | $8 |
| Metformin Hcl Er | 26 | $237 | $9 |
| Carvedilol | 11 | $234 | $21 |
| Simvastatin | 16 | $210 | $13 |
| Tamsulosin | 14 | $179 | $13 |
| Losartan-Hydrochlorothiazide | 15 | $166 | $11 |
| Lovastatin | 17 | $144 | $8 |
| Hydrochlorothiazide | 24 | $132 | $5 |
| Amlodipine Besylate-Benazepril | 12 | $119 | $10 |
| Montelukast | 11 | $113 | $10 |
| Atenolol | 14 | $107 | $8 |
| Omeprazole | 19 | $86 | $5 |
2015: 27 drugs
| Lantus Solostar | 12 | $11,602 | $967 |
| Januvia | 13 | $8,452 | $650 |
| Valsartan | 19 | $1,678 | $88 |
| Pravastatin | 43 | $1,638 | $38 |
| Bd Ultra-Fine Pen Needle | 25 | $1,205 | $48 |
| Metformin Hcl Er | 24 | $1,194 | $50 |
| Levothyroxine | 51 | $1,043 | $20 |
| Atorvastatin | 62 | $818 | $13 |
| Clopidogrel | 33 | $753 | $23 |
| Lansoprazole | 12 | $733 | $61 |
| Amlodipine Besylate | 98 | $726 | $7 |
| Metoprolol | 20 | $678 | $34 |
| Metformin | 72 | $563 | $8 |
| Losartan | 62 | $551 | $9 |
| Alendronate | 40 | $363 | $9 |
| Simvastatin | 36 | $311 | $9 |
| Carvedilol | 18 | $276 | $15 |
| Pioglitazone | 11 | $240 | $22 |
| Omeprazole | 22 | $160 | $7 |
| Atenolol | 18 | $149 | $8 |
| Hydralazine | 11 | $129 | $12 |
| Fluoxetine | 14 | $124 | $9 |
| Losartan-Hydrochlorothiazide | 15 | $107 | $7 |
| Lisinopril | 15 | $103 | $7 |
| Hydrochlorothiazide | 21 | $101 | $5 |
| Azithromycin | 14 | $97 | $7 |
| Furosemide | 17 | $93 | $5 |
2014: 30 drugs
| Lantus Solostar | 13 | $10,630 | $818 |
| Januvia | 22 | $9,874 | $449 |
| Humalog | 14 | $4,868 | $348 |
| Diovan | 14 | $4,019 | $287 |
| Atelvia | 11 | $3,377 | $307 |
| Pravastatin | 32 | $1,743 | $54 |
| Pioglitazone | 15 | $1,296 | $86 |
| Metformin | 106 | $1,148 | $11 |
| Bd Ultra-Fine Pen Needle | 21 | $1,032 | $49 |
| Amlodipine Besylate | 126 | $967 | $8 |
| Levothyroxine | 54 | $952 | $18 |
| Metoprolol | 14 | $804 | $57 |
| Simvastatin | 81 | $784 | $10 |
| Atorvastatin | 55 | $740 | $13 |
| Losartan | 67 | $727 | $11 |
| Alendronate | 70 | $716 | $10 |
| Ramipril | 20 | $485 | $24 |
| Clopidogrel | 21 | $448 | $21 |
| Metformin Hcl Er | 37 | $355 | $10 |
| Tamsulosin | 13 | $335 | $26 |
| Atenolol | 34 | $304 | $9 |
| Lovastatin | 21 | $291 | $14 |
| Lisinopril | 33 | $263 | $8 |
| Omeprazole | 29 | $245 | $8 |
| Metoprolol | 16 | $183 | $11 |
| Hydrochlorothiazide | 34 | $181 | $5 |
| Polyethylene Glycol 3350 | 11 | $159 | $14 |
| Propranolol | 13 | $132 | $10 |
| Paroxetine | 11 | $110 | $10 |
| Benazepril | 14 | $89 | $6 |
2013: 28 drugs
| Lantus Solostar | 18 | $9,941 | $552 |
| Januvia | 16 | $6,093 | $381 |
| Diovan | 20 | $4,951 | $248 |
| Benicar Hct | 11 | $3,505 | $319 |
| Clopidogrel | 17 | $1,578 | $93 |
| Atorvastatin | 50 | $1,413 | $28 |
| Metformin | 109 | $1,396 | $13 |
| Pioglitazone | 12 | $1,329 | $111 |
| Bd Ultra-Fine Pen Needle | 32 | $1,326 | $41 |
| Alendronate | 82 | $1,191 | $15 |
| Simvastatin | 105 | $1,119 | $11 |
| Losartan | 54 | $1,107 | $21 |
| Metoprolol | 16 | $1,024 | $64 |
| Pravastatin | 31 | $966 | $31 |
| Amlodipine Besylate | 91 | $858 | $9 |
| Metformin Hcl Er | 57 | $756 | $13 |
| Levothyroxine | 45 | $492 | $11 |
| Ramipril | 21 | $461 | $22 |
| Tamsulosin | 16 | $444 | $28 |
| Lisinopril | 58 | $411 | $7 |
| Carvedilol | 19 | $336 | $18 |
| Benazepril | 19 | $336 | $18 |
| Polyethylene Glycol 3350 | 12 | $302 | $25 |
| Atenolol | 24 | $288 | $12 |
| Lovastatin | 13 | $252 | $19 |
| Omeprazole | 19 | $235 | $12 |
| Hydrochlorothiazide | 26 | $138 | $5 |
| Propranolol | 12 | $96 | $8 |
Money from drug and device companies
$310 in 2025
| 2025 | 1 | 24 | None | $310 |
| 2024 | 1 | 20 | None | $255 |
| 2023 | 1 | 1 | None | $205 |
| 2022 | 1 | 1 | None | $370 |
| 2020 | 4 | 4 | None | $74 |
| 2019 | 9 | 25 | None | $523 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Sekisui Diagnostics | None | $310 | 1 payment
|
See the published payment
| Sekisui Diagnostics | Gift · 2025-01-29 | None | $310 |
See earlier years (2024, 2023, 2022, 2020, 2019)
2024: $255
| Sekisui Diagnostics | None | $255 | 1 payment
|
2023: $205
| Sekisui Diagnostics | None | $205 | 1 payment
|
2022: $370
| Sekisui Diagnostics | None | $370 | 1 payment
|
2020: $74
| Amgen | Evenity | $25 | 1 payment
|
| Amarin Pharma | Vascepa | $23 | 1 payment
|
| Lilly USA | Basaglar | $14 | 1 payment
|
| Merck Sharp & Dohme | Pneumovax 23 | $13 | 1 payment
|
2019: $523
| Amgen | Evenity | $166 | 6 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $75 | 4 payments
|
| Takeda Pharmaceuticals U.S.A. | Trintellix | $73 | 4 payments
|
| Merck Sharp & Dohme | Januvia | $63 | 4 payments
|
| Mylan Specialty L.P. | Yupelri | $43 | 2 payments
|
| Novo Nordisk | Levemir | $39 | 2 payments
|
| GlaxoSmithKline | Shingrix | $24 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $21 | 1 payment
|
| Sanofi Pasteur | Adacel | $19 | 1 payment
|
Professional record
- NPI
- 1669487112
- Licence
- CA C050043
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Medicaid ID
- CA C0500430
- Taxonomy
- Internal medicine (207R00000X)
- Mailing address
- 2204 Grant Rd, Suite 203, Mountain View, CA, 94040
- NPI first listed
- 2006-07-30
- NPI last updated
- 2015-01-16
This is when the NPI record was last certified, not a medical board exam.